Evidence map›Paper›PMID 38984111›Full record

ArticleFrontiers in ophthalmology2024

Editorial: Ocular fibrosis: molecular and cellular mechanisms and treatment modalities.

Christine M Sorenson, Teri L Belecky-Adams, Nader Sheibani

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christine M SorensonDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
Teri L Belecky-AdamsDepartment of Biology, Indiana University-Indianapolis, Indianapolis, IN, United States.
Nader SheibaniMcPherson Eye Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.

Funding

UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI Donna M Peters · 2005 to 2026
$12.6M
VEGF Antagonism and Resistance to Neovascular AMDR01EY030076 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SORENSON, CHRISTINE M · 2020 to 2023
$1.5M
Transforming Growth Factor Beta-Activated Kinase 1 (Tak1) in Retinal Microglial InflammationR15EY033968 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI BELECKY-ADAMS, TERI L · 2022 to 2022
$456k
NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY030076NEI NIH HHS R15 EY033968
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

extracellular matrixinflammationintegrinsmicroRNAmyofibroblastsocular fibrosis

Identifiers

PMID38984111
PMCPMC11182198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.